{"data":[{"accessionNo":"0001950047-26-008816","issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","personName":"CHRISTOPHER KENNEY","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7068,"aggregateMarketValue":437721.24,"unitsOutstanding":96840432,"approxSaleDate":"2026-08-28","exchange":"NASDAQ","filedAt":"2026-08-28"},{"accessionNo":"0001193125-26-349336","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"STEVEN GANNON","relationship":"Director","securityClass":"Common Shares","broker":"RBC Wealth Management","unitsToSell":10000,"aggregateMarketValue":640553,"unitsOutstanding":96840432,"approxSaleDate":"2026-08-11","exchange":"NASDAQ","filedAt":"2026-08-13"},{"accessionNo":"0001950047-26-005710","issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","personName":"GARY PATOU","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1322,"aggregateMarketValue":70052.78,"unitsOutstanding":96665550,"approxSaleDate":"2026-06-05","exchange":"NASDAQ","filedAt":"2026-06-05"},{"accessionNo":"0001950047-26-005712","issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC.","ticker":"XENE","personName":"GILLIAN CANNON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1190,"aggregateMarketValue":63058.1,"unitsOutstanding":96665550,"approxSaleDate":"2026-06-05","exchange":"NASDAQ","filedAt":"2026-06-05"},{"accessionNo":"0001193125-26-106680","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":7308,"aggregateMarketValue":403583,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-13","exchange":"NASDAQ","filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106682","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"CHRISTOPHER JOHN KENNEY","relationship":"Officer","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":1410,"aggregateMarketValue":77867,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-13","exchange":"NASDAQ","filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-106681","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"ANDREA DIFABIO","relationship":"Officer","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":1342,"aggregateMarketValue":74112,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-13","exchange":"NASDAQ","filedAt":"2026-03-13"},{"accessionNo":"0001193125-26-100797","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":11269,"aggregateMarketValue":677357,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10"},{"accessionNo":"0001193125-26-100799","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"CHRISTOPHER JOHN KENNEY","relationship":"Officer","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":2771,"aggregateMarketValue":166559,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10"},{"accessionNo":"0001193125-26-100805","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"ANDREA DIFABIO","relationship":"Officer","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":2607,"aggregateMarketValue":156702,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10"},{"accessionNo":"0001193125-26-098734","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":270000,"aggregateMarketValue":16289196,"unitsOutstanding":83190316,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09"},{"accessionNo":"0001193125-26-001168","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":40000,"aggregateMarketValue":1777166.23,"unitsOutstanding":77275005,"approxSaleDate":"2026-01-02","exchange":"NASDAQ","filedAt":"2026-01-02"},{"accessionNo":"0001193125-25-311409","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":10830,"aggregateMarketValue":495248,"unitsOutstanding":77275005,"approxSaleDate":"2025-12-08","exchange":"NASDAQ","filedAt":"2025-12-08"},{"accessionNo":"0001193125-25-310009","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":14375,"aggregateMarketValue":647360,"unitsOutstanding":77275005,"approxSaleDate":"2025-12-05","exchange":"NASDAQ","filedAt":"2025-12-05"},{"accessionNo":"0001193125-25-304226","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":97,"aggregateMarketValue":4366,"unitsOutstanding":77275005,"approxSaleDate":"2025-11-28","exchange":"NASDAQ","filedAt":"2025-12-01"},{"accessionNo":"0001193125-25-227196","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"IAN MORTIMER","relationship":"Officer, Director","securityClass":"Common Shares","broker":"Canaccord Genuity Corp.","unitsToSell":25000,"aggregateMarketValue":1004117,"unitsOutstanding":77105799,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01"},{"accessionNo":"0001193125-25-209529","issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","personName":"SHERRY AULIN","relationship":"Former officer","securityClass":"Common Shares","broker":"Morgan Stanley Wealth Management Canada Inc.","unitsToSell":2548,"aggregateMarketValue":94490,"unitsOutstanding":77105799,"approxSaleDate":"2025-09-19","exchange":"NASDAQ","filedAt":"2025-09-19"}],"updatedAt":"2026-10-13T05:26:15.444Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}